|
|
Volumn 11, Issue 6, 2010, Pages 519-520
|
|
Green tea and cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BORTEZOMIB;
EPIGALLOCATECHIN;
GREEN TEA EXTRACT;
PLACEBO;
POLYPHENOL;
PROTEASOME INHIBITOR;
ANTIANGIOGENIC ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
ANTIOXIDANT ACTIVITY;
APOPTOSIS;
ASIA;
BLADDER CANCER;
BREAST CANCER;
CANCER CELL;
CANCER INHIBITION;
CANCER RESEARCH;
CELL PROLIFERATION;
CLINICAL TRIAL;
CULTURAL FACTOR;
DRUG ABSORPTION;
DRUG CONTRAINDICATION;
DRUG INHIBITION;
DRUG METABOLISM;
DRUG SAFETY;
ENVIRONMENTAL FACTOR;
FOLLOW UP;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
INHIBITION KINETICS;
LUNG CANCER;
MALIGNANT NEOPLASTIC DISEASE;
METHODOLOGY;
NOTE;
NUTRITIONAL HEALTH;
OVARY CANCER;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY CONTROL;
TEA;
ANTICARCINOGENIC AGENTS;
ANTIOXIDANTS;
CATECHIN;
HUMANS;
NEOPLASMS;
TEA;
|
|
EID: 77953503097
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(10)70140-6 Document Type: Note |
|
Times cited : (9)
|
|
References (0)
|
